NA
Ricciuti B., Lamberti G., Roila F., Metro G. (2019). Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: An effective but still broken option. TRANSLATIONAL LUNG CANCER RESEARCH, 8(S4), S378-S382 [10.21037/tlcr.2019.04.15].
Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: An effective but still broken option
Ricciuti B.;Lamberti G.Writing – Original Draft Preparation
;
2019
Abstract
NAFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
